Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
about
Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlasIntermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sAn overview of current trends and gaps in patient-reported outcome measures used in haemophilia.Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden.[Total ankle replacement in patients with bleeding disorders].Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.Oral health in children and adolescents with haemophilia.Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.Effectiveness of two psychological interventions for pain management, emotional regulation and promotion of quality of life among adult Portuguese men with haemophilia (PSY-HaEMOPEQ): study protocol for a single-centre prospective randomised controlImproving haemophilia patient care through sharing best practice.Tailoring care to haemophilia patients' needs: which specialty and when?Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity.Analyses of joint health and influencing factors in different age groups of Chinese children with haemophilia.Imaging of haemophilic arthropathy: Awareness of pitfalls and need for standardization.Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.Guidelines for the management of hemophilia.Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study.European principles of inhibitor management in patients with haemophilia.Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
P2860
Q36908311-0F92ECDE-8A84-4EE1-8A64-EAB74F0FDA81Q37098836-16EC1233-2BDF-4E78-A411-771955481475Q38223329-A5F37825-F097-45E5-8B21-8E60D8956235Q38537167-E900D0DC-DAB5-4A95-8CC4-122F48D58511Q38955500-CAF9B2CD-9E9F-47C7-9A40-25B877E5F89CQ38982572-E5F3B990-3A89-4B16-BBC4-07BEA6EB25CAQ39189718-E79722D4-1B70-47C4-8373-4FACD1DFC46AQ40013630-9F91FAD0-970E-4449-A1B3-AFF3D7A1D5C1Q40593079-851C8F87-0B5D-4947-A122-1465319742E1Q40963236-571285AA-D15C-4A29-9A16-4BE24539C04AQ41430592-1092B3E8-C705-4C6C-8BDC-8B4513F83696Q41582321-5311B96B-14DD-4446-B8FC-5A777BAC2503Q42643647-7159C769-3CFC-425B-8D3B-C2082A4AA1EFQ43198121-75FF57D7-2600-4AEB-AAFB-69FD2127EA77Q44184274-63E99F42-5CDA-4520-B7DB-19F1C6376E46Q45861087-568B69C1-1C51-4E5C-98DB-F42FF2C26C7DQ45869055-2A13CEAA-F618-410F-B406-5E781B77E885Q45875118-1E482874-877D-4E6F-B87B-C7082CAC0BFFQ45880345-43521161-E7C0-4A6B-BC60-4951E5EED6F5Q45880913-2A3502D4-F28B-405E-93CE-EFEAAD1A4724Q45888176-FBFA2BC4-C0B4-48D4-B032-99348789AF59Q54981504-C43BE6E6-4B68-441B-A7AC-6A09074B943EQ57179210-7B707BC4-1720-4601-8265-9F80617F2773
P2860
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@en
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@nl
type
label
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@en
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@nl
prefLabel
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@en
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@nl
P2093
P2860
P1433
P1476
Recommendations for assessment, monitoring and follow-up of patients with haemophilia.
@en
P2093
A Batorova
J Astermark
P de Moerloose
P2860
P304
P356
10.1111/J.1365-2516.2011.02671.X
P577
2011-10-13T00:00:00Z